Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
828.50 GBX | -3.21% | -7.27% | -21.02% |
08-28 | Citi raises Direct Line Insurance to 'buy' | AN |
08-19 | UBS likes Admiral; JPMorgan raises Aviva PT | AN |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 18.58 | 11.47 | 10.95 | 5.91 | 3.1 | |||||
Return on Total Capital | 21.63 | 13.29 | 12.89 | 7.08 | 3.81 | |||||
Return On Equity % | 28.59 | 17.42 | 16.7 | 9.56 | 6.46 | |||||
Return on Common Equity | 28.59 | 17.42 | 16.7 | 9.56 | 6.46 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 50.48 | 46.13 | 42.08 | 34.5 | 32.11 | |||||
SG&A Margin | 21.8 | 24.24 | 22.08 | 24.25 | 25.55 | |||||
EBITDA Margin % | 28.6 | 21.62 | 19.13 | 10.08 | 5.38 | |||||
EBITA Margin % | 27.98 | 20.79 | 18.32 | 9.32 | 4.67 | |||||
EBIT Margin % | 27.72 | 20.35 | 17.87 | 8.89 | 4.25 | |||||
Income From Continuing Operations Margin % | 22.46 | 16.54 | 14.34 | 7.23 | 4.23 | |||||
Net Income Margin % | 22.46 | 16.54 | 14.34 | 7.23 | 4.23 | |||||
Net Avail. For Common Margin % | 22.46 | 16.54 | 14.34 | 7.23 | 4.23 | |||||
Normalized Net Income Margin | 17.39 | 12.79 | 11.17 | 5.63 | 2.9 | |||||
Levered Free Cash Flow Margin | 20.54 | 12.27 | 10.37 | 0.22 | -5.27 | |||||
Unlevered Free Cash Flow Margin | 20.59 | 12.32 | 10.43 | 0.3 | -5.16 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.07 | 0.9 | 0.98 | 1.06 | 1.17 | |||||
Fixed Assets Turnover | 54.27 | 35.01 | 36.39 | 19.56 | 14.78 | |||||
Receivables Turnover (Average Receivables) | 4.95 | 5.1 | 5.85 | 5.7 | 5.19 | |||||
Inventory Turnover (Average Inventory) | 5.25 | 4.56 | 4.81 | 4.68 | 3.87 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 6.33 | 5.37 | 5.43 | 4 | 3.71 | |||||
Quick Ratio | 5.6 | 4.39 | 4.58 | 2.83 | 2.49 | |||||
Operating Cash Flow to Current Liabilities | 2.05 | 0.85 | 0.92 | 0.15 | -0.06 | |||||
Days Sales Outstanding (Average Receivables) | 73.77 | 71.79 | 62.36 | 64.08 | 70.27 | |||||
Days Outstanding Inventory (Average Inventory) | 69.46 | 80.18 | 75.86 | 77.94 | 94.2 | |||||
Average Days Payable Outstanding | 23.73 | 18.45 | 41.59 | 32.42 | 33.65 | |||||
Cash Conversion Cycle (Average Days) | 119.5 | 133.52 | 96.62 | 109.6 | 130.82 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.8 | 0.75 | 1.03 | 7.07 | 6.39 | |||||
Total Debt / Total Capital | 0.79 | 0.75 | 1.02 | 6.6 | 6.01 | |||||
LT Debt/Equity | 0.53 | 0.44 | 0.75 | 5.64 | 4.96 | |||||
Long-Term Debt / Total Capital | 0.53 | 0.43 | 0.74 | 5.27 | 4.66 | |||||
Total Liabilities / Total Assets | 13.21 | 15.35 | 16.22 | 23.23 | 24.2 | |||||
EBIT / Interest Expense | 361 | 256.5 | 185.33 | 76.5 | 25.83 | |||||
EBITDA / Interest Expense | 375.5 | 275.5 | 200.67 | 91 | 38.83 | |||||
(EBITDA - Capex) / Interest Expense | 362.5 | 262.5 | 188.67 | 79.5 | 34.5 | |||||
Total Debt / EBITDA | 0.02 | 0.03 | 0.05 | 0.46 | 0.65 | |||||
Net Debt / EBITDA | -1.68 | -2.56 | -2.71 | -2.15 | -1.92 | |||||
Total Debt / (EBITDA - Capex) | 0.02 | 0.04 | 0.05 | 0.53 | 0.73 | |||||
Net Debt / (EBITDA - Capex) | -1.74 | -2.69 | -2.89 | -2.47 | -2.16 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 9.73 | -3.22 | 23.4 | 10.67 | 5.84 | |||||
Gross Profit, 1 Yr. Growth % | 7 | -11.56 | 12.55 | -9.24 | -1.52 | |||||
EBITDA, 1 Yr. Growth % | -2.99 | -26.85 | 9.17 | -41.68 | -43.52 | |||||
EBITA, 1 Yr. Growth % | -4.2 |